LexDanaLexDanabeta
Inventor

CHONG-KYO LEE

Inventor
KR

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
Y02ATechnologies for adaptation to climate change18%
PatentTitleYear
12,286,423Antiviral 1,3-di-oxo-indene compounds202512,083,092Antiviral 1,3-di-oxo-indene compounds202411,214,570Pyrrolopyridine derivative, method for producing same, and use thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to ST PHARM CO LTD (1)· patent assignee history
2022–2025Based in KR· patent location history
2024–2025Patents assigned to KOREA RES INST CHEMICAL TECH (2)· patent assignee history
2024–2025Patents assigned to NOVARTIS AG (2)· patent assignee history
2024–2025Patents assigned to UNIV LEUVEN KATH (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
KOREA RES INST CHEMICAL TECH22024–2025
NOVARTIS AG22024–2025
UNIV LEUVEN KATH22024–2025
ST PHARM CO LTD12022
Locations
LocationPatentsSpan
KR32022–2025